
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5141301
[patent_doc_number] => 20070003517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Inhibitors of the JNK signal transduction pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/474513
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17936
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003517.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474513 | Inhibitors of the JNK signal transduction pathway and methods of use | Jun 22, 2006 | Issued |
Array
(
[id] => 6105905
[patent_doc_number] => 20110167505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'GFATS As Modifiers of the AXIN Pathway and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/993190
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15585
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20110167505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993190 | GFATS As Modifiers of the AXIN Pathway and Methods of Use | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5858026
[patent_doc_number] => 20060228407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Enhanced delivery via serpin enzyme complex receptor'
[patent_app_type] => utility
[patent_app_number] => 11/455791
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228407.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455791 | Enhanced delivery via serpin enzyme complex receptor | Jun 19, 2006 | Abandoned |
Array
(
[id] => 64335
[patent_doc_number] => 07759467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Enhanced mediated DNA transfer'
[patent_app_type] => utility
[patent_app_number] => 11/453658
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14656
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453658
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453658 | Enhanced mediated DNA transfer | Jun 14, 2006 | Issued |
Array
(
[id] => 5889902
[patent_doc_number] => 20060276426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/448365
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22361
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11448365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/448365 | Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor | Jun 5, 2006 | Abandoned |
Array
(
[id] => 5241746
[patent_doc_number] => 20070020238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Method of targeted gene delivery using viral vectors'
[patent_app_type] => utility
[patent_app_number] => 11/446353
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23627
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446353 | Method of targeted gene delivery using viral vectors | May 31, 2006 | Abandoned |
Array
(
[id] => 4971193
[patent_doc_number] => 20070111195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Toxicity typing using liver stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/445733
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19481
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111195.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445733
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445733 | Toxicity typing using liver stem cells | May 31, 2006 | Issued |
Array
(
[id] => 8858398
[patent_doc_number] => 08460932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Method of treating a disorder by suicide gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/444050
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14590
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11444050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/444050 | Method of treating a disorder by suicide gene therapy | May 30, 2006 | Issued |
Array
(
[id] => 10522904
[patent_doc_number] => 09249404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Coagulation factor X polypeptides with modified activation properties'
[patent_app_type] => utility
[patent_app_number] => 11/921399
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 3
[patent_no_of_words] => 8033
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921399 | Coagulation factor X polypeptides with modified activation properties | May 29, 2006 | Issued |
Array
(
[id] => 5385744
[patent_doc_number] => 20090226989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Genetically modified yeast of the species issatchenkia orientalis and closely relates species, and fermentation processes using same'
[patent_app_type] => utility
[patent_app_number] => 11/921161
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14591
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921161
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921161 | Genetically modified yeast of the species Issatchenkia orientalis and closely relates species, and fermentation processes using same | May 29, 2006 | Issued |
Array
(
[id] => 5141308
[patent_doc_number] => 20070003524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Targeted retrograde gene delivery to motor neurons'
[patent_app_type] => utility
[patent_app_number] => 11/442504
[patent_app_country] => US
[patent_app_date] => 2006-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12079
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003524.pdf
[firstpage_image] =>[orig_patent_app_number] => 11442504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/442504 | Targeted retrograde gene delivery to motor neurons | May 24, 2006 | Issued |
Array
(
[id] => 5514858
[patent_doc_number] => 20090215165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'High-level expression of recombinant antibody in a mammalian host cell'
[patent_app_type] => utility
[patent_app_number] => 11/920653
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11669
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920653 | High-level expression of recombinant antibody in a mammalian host cell | May 18, 2006 | Abandoned |
Array
(
[id] => 5050845
[patent_doc_number] => 20070031390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Methods and compositions for site-specific genomic expression of nucleic acid sequences'
[patent_app_type] => utility
[patent_app_number] => 11/436357
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14471
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436357 | Methods and compositions for site-specific genomic expression of nucleic acid sequences | May 17, 2006 | Abandoned |
Array
(
[id] => 4954496
[patent_doc_number] => 20080187520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Tool for the transfer and production of proteins using the pseudomonas type III secretion system'
[patent_app_type] => utility
[patent_app_number] => 11/433391
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9815
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187520.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433391 | Tool for the transfer and production of proteins using the pseudomonas type III secretion system | May 11, 2006 | Issued |
Array
(
[id] => 8652851
[patent_doc_number] => 08372597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Methods of screening for introduction of DNA into a target cell'
[patent_app_type] => utility
[patent_app_number] => 11/429391
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22934
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11429391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429391 | Methods of screening for introduction of DNA into a target cell | May 3, 2006 | Issued |
Array
(
[id] => 5618989
[patent_doc_number] => 20060188522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Viral agents'
[patent_app_type] => utility
[patent_app_number] => 11/416160
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14492
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188522.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416160
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416160 | Viral agents | May 2, 2006 | Abandoned |
Array
(
[id] => 63471
[patent_doc_number] => 07759097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Vector for transformation of Labyrinthulomycota'
[patent_app_type] => utility
[patent_app_number] => 11/413141
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 10434
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413141 | Vector for transformation of Labyrinthulomycota | Apr 27, 2006 | Issued |
Array
(
[id] => 5618951
[patent_doc_number] => 20060188484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Virus vectors and methods of making and administering the same'
[patent_app_type] => utility
[patent_app_number] => 11/414319
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29787
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188484.pdf
[firstpage_image] =>[orig_patent_app_number] => 11414319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/414319 | Virus vectors and methods of making and administering the same | Apr 27, 2006 | Abandoned |
Array
(
[id] => 5618950
[patent_doc_number] => 20060188483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Virus vectors and methods of making and administering the same'
[patent_app_type] => utility
[patent_app_number] => 11/413819
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29823
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413819 | Virus vectors and methods of making and administering the same | Apr 27, 2006 | Abandoned |
Array
(
[id] => 5508435
[patent_doc_number] => 20090081642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Novel apoptosis gene EI24, compositions, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/408067
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19717
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11408067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/408067 | Novel apoptosis gene EI24, compositions, and methods of use | Apr 20, 2006 | Abandoned |